Whitener Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,239
Closed -$209K 138
2022
Q4
$209K Buy
2,239
+82
+4% +$7.91K 0.09% 127
2022
Q3
$205K Buy
+2,157
New +$214K 0.1% 127
2022
Q2
Sell
-2,157
Closed -$218K 140
2022
Q1
$218K Buy
2,157
+100
+5% +$10.5K 0.08% 135
2021
Q4
$212K Buy
+2,057
New +$190K 0.08% 137
2019
Q4
Sell
-631
Closed -$39K 205
2019
Q3
$39K Buy
631
+186
+42% +$11K 0.02% 247
2019
Q2
$24K Sell
445
-50
-10% -$2.69K 0.01% 275
2019
Q1
$26K Hold
495
0.02% 264
2018
Q4
$32K Buy
495
+106
+27% +$7.91K 0.02% 226
2018
Q3
$30K Buy
+389
New +$27.8K 0.02% 250
2018
Q2
Sell
-389
Closed -$24K 177
2018
Q1
$24K Sell
389
-330
-46% -$23.7K 0.02% 258
2017
Q4
$52K Buy
+719
New +$52.3K 0.04% 184

Other funds holding CVS

Whitener Capital Management's CVS Position: Q1 2023 in Review

Whitener Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,239 shares — an estimated $209K sold.

Whitener Capital Management first reported a position in CVS in Q4 2017 and held it in 11 quarters. The position peaked at $218K in Q1 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Whitener Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Whitener Capital Management sold 2,239 CVS Health shares in Q1 2023, an estimated $209K.
  • Whitener Capital Management first reported a position in CVS Health in Q4 2017 and held it in 11 quarters.
  • Whitener Capital Management's CVS Health position peaked at $218K in Q1 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Whitener Capital Management's 13F filing for Q1 2023, filed 12 Apr 2023.